Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function

Jennifer L. Schwedlera Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Maxwell A. Stefana Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Christine E. Thatchera Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Peter R. McIlroya Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Anupama Sinhaa Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Ashlee M. Phillipsb Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USAView further author information

Christopher A. Sumnera Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Colleen M. Courtneya Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Christina Y. Kima Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USAView further author information

Dina R. Weilhammerb Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USAView further author information

Brooke Harmona Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA, USACorrespondence[email protected]

Your download is now in progress and you may close this window